iSpecimen Inc. Share-based Payment Arrangement, Expense
iSpecimen Inc. (ISPC) reported Share-based Payment Arrangement, Expense of $18.09 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-08-06
- iSpecimen Inc. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $18.09K, a 40.80% decline year-over-year.
- iSpecimen Inc. share-based payment arrangement, expense for the quarter ending 2023-06-30 was $30.57K.
- iSpecimen Inc. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $399.82K, a 1265.18% increase year-over-year.
- iSpecimen Inc. share-based payment arrangement, expense for the quarter ending 2021-06-30 was $28.37K, a 3.12% decline year-over-year.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month |
|---|---|---|---|
| 2024-06-30 | $18.09K 10-Q · filed 2024-08-06 | ||
| 2023-06-30 | $30.57K 10-Q · filed 2024-08-06 | ||
| 2021-09-30 | $399.82K 10-Q · filed 2021-11-04 | $428.19K derived: sum of 2 quarters · filed 2021-11-04 | $450.23K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $28.37K 10-Q · filed 2021-08-10 | $50.41K 10-Q · filed 2021-08-10 | |
| 2020-09-30 | $29.29K 10-Q · filed 2021-11-04 | $58.57K derived: sum of 2 quarters · filed 2021-11-04 | $80.60K 10-Q · filed 2021-11-04 |
| 2020-06-30 | $29.29K 10-Q · filed 2021-08-10 | $51.33K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |